Report post

Does 23andMe have full year guidance?

23andme reconfirmed its full year guidance following Q1 FY2023 results. Full year revenue for fiscal 2023, which will end on March 31, 2023, is projected to be in the range of $260 to $280 million, with a net loss in the range of $350 to $370 million.

How did 23andMe perform in Q1 fy2023?

23andMe ended Q1 FY2023 with cash of $479 million, compared to $553 million as of March 31, 2022. The decrease was primarily attributable to the Company's overall operating cash flow deficit. 23andme reconfirmed its full year guidance following Q1 FY2023 results.

How many customers does 23andMe+ have?

Expanded customer database to approximately 13.1 million genotyped customers. Launched three new reports for customers subscribed to 23andMe+, a membership service that offers insights and features to give members even more actionable information to live healthier lives.

The World's Leading Crypto Trading Platform

Get my welcome gifts